No evidence for involvement of β-catenin and APC in urothelial carcinomas

  • Authors:
    • Robert Stoehr
    • Rene C. Krieg
    • Ruth Knuechel
    • Ferdinand Hofstaedter
    • Christian Pilarsky
    • Dirk Zaak
    • Ruediger Schmitt
    • Arndt Hartmann
  • View Affiliations

  • Published online on: May 1, 2002     https://doi.org/10.3892/ijo.20.5.905
  • Pages: 905-911
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The wnt pathway plays an important role in embryonal patterning and cell fate determination, involving stabilization of nuclear and cytoplasmic β-catenin (CTNNB1) mediated by APC, axin, and other proteins. Uncomplexed β-catenin binds to TCF/LEF transcription factors and activates the expression of growth regulatory target genes such as c-myc or cyclin D1. In colorectal and other cancers, constitutive wnt signaling results frequently from mutations in one or more pathway components, e.g. APC and β-catenin, resulting in nuclear and/or cytoplasmic accumulation of β-catenin. In the present study, the most frequent alterations in the CTNNB1 and APC genes were investigated in primary urothelial bladder tumors and cell lines. Snap-frozen bladder tumors (n=99) of different stages and grades and 4 cell lines (RT4, RT112, J82, UROtsa) were investigated for APC allelic deletions by loss of heterozygosity (LOH) analysis. The most frequent mutated regions of CTNNB1 (degradation box in the third exon) and APC (mutation cluster region) were directly sequenced. β-catenin expression was analyzed by immunofluorescence in the cell lines. LOH at the APC gene locus on chromosome 5q21 was found in 7 of 72 (10%) of the informative cases. No mutations were found in either CTNNB1 or APC. A previously described polymorphism at codon 1493 of the APC gene was detected in 8 tumors and 3 cell lines. All cell lines showed normal membranous β-catenin staining without evidence for nuclear or cytoplasmic accumulation. Alteration of APC and β-catenin, which are the most frequent wnt pathway alterations in many tumor types, are rare events in urothelial carcinomas. Other wnt pathway members, such as axin, may play an important role in urothelial carcinogenesis.

Related Articles

Journal Cover

May 2002
Volume 20 Issue 5

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Stoehr R, Krieg RC, Knuechel R, Hofstaedter F, Pilarsky C, Zaak D, Schmitt R and Hartmann A: No evidence for involvement of β-catenin and APC in urothelial carcinomas. Int J Oncol 20: 905-911, 2002
APA
Stoehr, R., Krieg, R.C., Knuechel, R., Hofstaedter, F., Pilarsky, C., Zaak, D. ... Hartmann, A. (2002). No evidence for involvement of β-catenin and APC in urothelial carcinomas. International Journal of Oncology, 20, 905-911. https://doi.org/10.3892/ijo.20.5.905
MLA
Stoehr, R., Krieg, R. C., Knuechel, R., Hofstaedter, F., Pilarsky, C., Zaak, D., Schmitt, R., Hartmann, A."No evidence for involvement of β-catenin and APC in urothelial carcinomas". International Journal of Oncology 20.5 (2002): 905-911.
Chicago
Stoehr, R., Krieg, R. C., Knuechel, R., Hofstaedter, F., Pilarsky, C., Zaak, D., Schmitt, R., Hartmann, A."No evidence for involvement of β-catenin and APC in urothelial carcinomas". International Journal of Oncology 20, no. 5 (2002): 905-911. https://doi.org/10.3892/ijo.20.5.905